1 Preface
2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary
4 Japan Cell and Gene Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cell and Gene Therapy Market Landscape

5.1 Historical and Current Market Trends (​2019-2022)
5.2 Market Forecast (​2023-2032​)

6 Japan Cell and Gene Therapy Market - Breakup by Therapy Type

6.1 Cell Therapy
6.1.1 Overview
6.1.2 Historical and Current Market Trends (​2019-2022)
6.1.3 Market Segmentation
6.1.3.1 Stem Cell
6.1.3.2 Non-Stem Cell
6.1.4 Market Forecast (​2023-2032​)
6.2 Gene Therapy
6.2.1 Overview
6.2.2 Historical and Current Market Trends (​2019-2022)
6.2.3 Market Forecast (​2023-2032​)

7 Japan Cell and Gene Therapy Market - Breakup by Indication

7.1 Cardiovascular Disease
7.1.1 Overview
7.1.2 Historical and Current Market Trends (​2019-2022)
7.1.3 Market Forecast (​2023-2032​)
7.2 Oncology Disorder
7.2.1 Overview
7.2.2 Historical and Current Market Trends (​2019-2022)
7.2.3 Market Forecast (​2023-2032​)
7.3 Genetic Disorder
7.3.1 Overview
7.3.2 Historical and Current Market Trends (​2019-2022)
7.3.3 Market Forecast (​2023-2032​)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Historical and Current Market Trends (​2019-2022)
7.4.3 Market Forecast (​2023-2032​)
7.5 Neurological Disorder
7.5.1 Overview
7.5.2 Historical and Current Market Trends (​2019-2022)
7.5.3 Market Forecast (​2023-2032​)
7.6 Others
7.6.1 Historical and Current Market Trends (​2019-2022)
7.6.2 Market Forecast (​2023-2032​)

8 Japan Cell and Gene Therapy Market - Breakup by Delivery Mode

8.1 In-Vivo
8.1.1 Overview
8.1.2 Historical and Current Market Trends (​2019-2022)
8.1.3 Market Forecast (​2023-2032​)
8.2 Ex-Vivo
8.2.1 Overview
8.2.2 Historical and Current Market Trends (​2019-2022)
8.2.3 Market Forecast (​2023-2032​)

9 Japan Cell and Gene Therapy Market - Breakup by End User

9.1 Hospitals
9.1.1 Overview
9.1.2 Historical and Current Market Trends (​2019-2022)
9.1.3 Market Forecast (​2023-2032​)
9.2 Cancer Care Centers
9.2.1 Overview
9.2.2 Historical and Current Market Trends (​2019-2022)
9.2.3 Market Forecast (​2023-2032​)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Historical and Current Market Trends (​2019-2022)
9.3.3 Market Forecast (​2023-2032​)
9.4 Others
9.4.1 Historical and Current Market Trends (​2019-2022)
9.4.2 Market Forecast (​2023-2032​)

10 Japan Cell and Gene Therapy Market – Breakup by Region

10.1 Kanto Region
10.1.1 Overview
10.1.2 Historical and Current Market Trends (​2019-2022)
10.1.3 Market Breakup by Therapy Type
10.1.4 Market Breakup by Indication
10.1.5 Market Breakup by Delivery Mode
10.1.6 Market Breakup by End User
10.1.7 Key Players
10.1.8 Market Forecast (​2023-2032​)
10.2 Kansai/Kinki Region
10.2.1 Overview
10.2.2 Historical and Current Market Trends (​2019-2022)
10.2.3 Market Breakup by Therapy Type
10.2.4 Market Breakup by Indication
10.2.5 Market Breakup by Delivery Mode
10.2.6 Market Breakup by End User
10.2.7 Key Players
10.2.8 Market Forecast (​2023-2032​)
10.3 Central/ Chubu Region
10.3.1 Overview
10.3.2 Historical and Current Market Trends (​2019-2022)
10.3.3 Market Breakup by Therapy Type
10.3.4 Market Breakup by Indication
10.3.5 Market Breakup by Delivery Mode
10.3.6 Market Breakup by End User
10.3.7 Key Players
10.3.8 Market Forecast (​2023-2032​)
10.4 Kyushu-Okinawa Region
10.4.1 Overview
10.4.2 Historical and Current Market Trends (​2019-2022)
10.4.3 Market Breakup by Therapy Type
10.4.4 Market Breakup by Indication
10.4.5 Market Breakup by Delivery Mode
10.4.6 Market Breakup by End User
10.4.7 Key Players
10.4.8 Market Forecast (​2023-2032​)
10.5 Tohoku Region
10.5.1 Overview
10.5.2 Historical and Current Market Trends (​2019-2022)
10.5.3 Market Breakup by Therapy Type
10.5.4 Market Breakup by Indication
10.5.5 Market Breakup by Delivery Mode
10.5.6 Market Breakup by End User
10.5.7 Key Players
10.5.8 Market Forecast (​2023-2032​)
10.6 Chugoku Region
10.6.1 Overview
10.6.2 Historical and Current Market Trends (​2019-2022)
10.6.3 Market Breakup by Therapy Type
10.6.4 Market Breakup by Indication
10.6.5 Market Breakup by Delivery Mode
10.6.6 Market Breakup by End User
10.6.7 Key Players
10.6.8 Market Forecast (​2023-2032​)
10.7 Hokkaido Region
10.7.1 Overview
10.7.2 Historical and Current Market Trends (​2019-2022)
10.7.3 Market Breakup by Therapy Type
10.7.4 Market Breakup by Indication
10.7.5 Market Breakup by Delivery Mode
10.7.6 Market Breakup by End User
10.7.7 Key Players
10.7.8 Market Forecast (​2023-2032​)
10.8 Shikoku Region
10.8.1 Overview
10.8.2 Historical and Current Market Trends (​2019-2022)
10.8.3 Market Breakup by Therapy Type
10.8.4 Market Breakup by Indication
10.8.5 Market Breakup by Delivery Mode
10.8.6 Market Breakup by End User
10.8.7 Key Players
10.8.8 Market Forecast (​2023-2032​)

11 Japan Cell and Gene Therapy Market – Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 CORESTEM Inc.
12.1.1 Business Overview
12.1.2 Services Offered
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Helixmith Co. Ltd.
12.2.1 Business Overview
12.2.2 Services Offered
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 JCR Pharmaceuticals Co. Ltd.
12.3.1 Business Overview
12.3.2 Services Offered
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Others
12.4.1 Business Overview
12.4.2 Services Offered
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events

13 Japan Cell and Gene Therapy Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.2.1 Growth in the Prevalence of Chronic Diseases
13.1.3 Restraints
13.1.3.1 High Costs and Failure Rate in Clinical Trials
13.1.4 Opportunities
13.1.4.1 Growth in Strategic Alliances
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis

14 Appendix